Sunshine Lake Pharma Co., Ltd. - H Shares Stock: price and insider trades · Hong Kong

This page follows insider dealings at Sunshine Lake Pharma Co., Ltd. - H Shares as filed with HKEX, a company from the Health Care sector. In the past year (23 October 2025 to 23 October 2026), 21 filings came from 6 insiders.

Open-market activity splits into 15 purchases totalling €13.2M and 5 sales; 5 insiders sit on the buying side and 5 insiders on the selling side. No amount is published for 10 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Among those who bought: 5 senior executives. The largest single trade was a purchase of €5.5M by Zhang Yushuai, published on 3 August 2026, equal to 0.12% of the market capitalisation.

For context, the typical company on the same exchange (median of 1,315 companies) published 4 filings over the same period, against 21 filings here. Since 2026, the database holds 15 purchases and 5 sales by insiders of the company.

The last insider purchase was made public on 7 October 2026, 17 days ago. The median gap between a trade and its publication by HKEX is 6 days. That lag is the time during which only the insider knows about the trade.

Elsewhere in the same sector, our signals recently picked up insider purchases at EssilorLuxottica and Dynavox Group AB. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.